Share
Journal Information
Special content about coronavirus SARS-CoV-2 (COVID-19) in Hematology, Transfusion and Cell Therapy
Peripheral lymphocyte subsets as predicting factors for molecular recurrence after imatinib discontinuation in a phase 2 imatinib discontinuation trial in patients with chronic myeloid leukemia
Arthur Gomes Oliveira Braga, Katia Borgia Barbosa Pagnano, Marina Dal'Bó Pelegrini Campioni, Ana Beatriz Pascoal Lopes, Gislaine Oliveira Duarte, Konradin Metze, Irene Lorand-Metze
10.1016/j.htct.2023.06.001
Full text access
Available online 11 July 2023
Comparison of characteristics and laboratory tests of COVID-19 hematological patients from France and Brazil during the pre-vaccination period: identification of prognostic profiles for survival
Lilith Faucheux, Lucas Bassolli de Oliveira Alves, Sylvie Chevret, Vanderson Rocha
10.1016/j.htct.2022.05.003
Hematol Transfus Cell Ther. 2023;45:306-16
Full text access
Evaluation of lymphocyte count, T-cell subsets and neutrophil-to-lymphocyte ratio as early predictors for severity and outcome of COVID-19 disease–a report from a highly complex hospital in Brazil
Douglas Câmara de Oliveira, Beatriz Sanada Spiri, Yara Carolina Schluga, Julie Lilian Pimentel Justus, Francisco Diego Negrão Lopes Neto, Ana Paula de Azambuja
10.1016/j.htct.2022.05.007
Hematol Transfus Cell Ther. 2023;45:330-7
Full text access
Autoimmune hemolytic anemia and COVID-19 vaccination
Jeremy W. Jacobs
10.1016/j.htct.2022.08.007
Hematol Transfus Cell Ther. 2023;45:410-1
Full text access
Effects of therapeutic plasma exchange on a cohort of patients with severe coronavirus infection: real world evidence from Brazil
Paula Menezes Schiefferdecker, Iara Buselato Chen, Fernanda Bronzel Bher, Leonardo Klettenberg Aciolli, Geovana Bodanese, Lucas Miyake Okumura, Paulo Tadeu Rodrigues de Almeida
10.1016/j.htct.2023.01.004
Hematol Transfus Cell Ther. 2023;45 Supl 2:S148-52
Full text access
Thrombotic thrombocytopenic purpura and mushroom-shaped red blood cells secondary to COVID-19: A case report
Tarcísio Silva Borborema, Joziele de Souza Lima, Júlio César Moreira Brito, Mitiko Murao, Rodrigo Siqueira-Batista
10.1016/j.htct.2023.01.001
Full text access
Available online 7 February 2023
Coincidental or causal? A case report of acquired thrombotic thrombocytopenic purpura following mRNA-1273 Covid-19 vaccination
Erinie M Mekheal, Christopher Millet, Nader Mekheal, Moutaz Ghrewati, Ashesha Mechineni, Michael Maroules
10.1016/j.htct.2022.09.1278
Full text access
Available online 22 January 2023
EFFICACY AND SAFETY OF NIPOCALIMAB, AN FCRN BLOCKER, IN WARM AUTOIMMUNE HEMOLYTIC ANEMIA (WAIHA): ENERGY PHASE 2/3 STUDY DESIGN
I Murakhovskaya, B Fattizzo, D Cueto, AB Perdomo, M Jouvin
10.1016/j.htct.2022.09.019
Hematol Transfus Cell Ther. 2022;44 Supl 2:S11
Open access
A PHASE 2/3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF MITAPIVAT IN PATIENTS WITH SICKLE CELL DISEASE
KH Kuo, A Oluyadi, H Shao, S Morris, AU Zaidi, EJV Beers, SL Thein
10.1016/j.htct.2022.09.021
Hematol Transfus Cell Ther. 2022;44 Supl 2:S12-3
Open access
PIRTOBRUTINIB, A HIGHLY SELECTIVE, NON-COVALENT (REVERSIBLE) BTK INHIBITOR IN PREVIOUSLY TREATED MANTLE CELL LYMPHOMA: UPDATED RESULTS FROM THE PHASE 1/2 BRUIN STUDY
RRBN Presenter, N Shah, A Alencar, J Gerson, M Patel, W Jurczak, K Patel, A Mato, C Cheah, M Wang
10.1016/j.htct.2022.09.214
Hematol Transfus Cell Ther. 2022;44 Supl 2:S127
Open access
Special content about COVID-19
Publish in
Hematology, Transfusion and Cell Therapy
Hematology, Transfusion and Cell Therapy is a member and subscribes the principles of, the Committee on Publication Ethics (COPE)
www.publicationethics.org.
www.publicationethics.org.